
Edward A. Miller
Examiner (ID: 14808)
| Most Active Art Unit | 2204 |
| Art Unit(s) | 2899, 2605, 2203, 1801, 3641, 2200, 2204, 1802 |
| Total Applications | 1187 |
| Issued Applications | 889 |
| Pending Applications | 53 |
| Abandoned Applications | 244 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5290478
[patent_doc_number] => 20090023208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Cultivation of Primate Embryonic Cells'
[patent_app_type] => utility
[patent_app_number] => 12/240640
[patent_app_country] => US
[patent_app_date] => 2008-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5757
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023208.pdf
[firstpage_image] =>[orig_patent_app_number] => 12240640
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/240640 | Cultivation of Primate Embryonic Cells | Sep 28, 2008 | Abandoned |
Array
(
[id] => 5485363
[patent_doc_number] => 20090275128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'MEDIUM AND CULTURE OF EMBRYONIC STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/209325
[patent_app_country] => US
[patent_app_date] => 2008-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3975
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275128.pdf
[firstpage_image] =>[orig_patent_app_number] => 12209325
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/209325 | MEDIUM AND CULTURE OF EMBRYONIC STEM CELLS | Sep 11, 2008 | Abandoned |
Array
(
[id] => 5954505
[patent_doc_number] => 20110034540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'Use of the CYP46A1 Gene for the Treatment of Alzheimer\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 12/678020
[patent_app_country] => US
[patent_app_date] => 2008-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10653
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034540.pdf
[firstpage_image] =>[orig_patent_app_number] => 12678020
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/678020 | CYP46A1 gene for the treatment of alzheimer's disease | Sep 10, 2008 | Issued |
Array
(
[id] => 5504466
[patent_doc_number] => 20090165154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'Transgenic ungulates having reduced prion protein activity and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/231873
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 75
[patent_no_of_words] => 70632
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20090165154.pdf
[firstpage_image] =>[orig_patent_app_number] => 12231873
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/231873 | Transgenic bovine having reduced prion protein activity and uses thereof | Sep 4, 2008 | Issued |
Array
(
[id] => 5423186
[patent_doc_number] => 20090149642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'ENRICHED PREPARATION OF HUMAN FETAL MULTIPOTENTIAL NEURAL STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/202879
[patent_app_country] => US
[patent_app_date] => 2008-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 10954
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149642.pdf
[firstpage_image] =>[orig_patent_app_number] => 12202879
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/202879 | ENRICHED PREPARATION OF HUMAN FETAL MULTIPOTENTIAL NEURAL STEM CELLS | Sep 1, 2008 | Abandoned |
Array
(
[id] => 5539687
[patent_doc_number] => 20090221492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'EXPRESSION OF ACTIVE HUMAN FACTOR IX IN MAMMARY TISSUE OF TRANSGENIC ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 12/201673
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13116
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221492.pdf
[firstpage_image] =>[orig_patent_app_number] => 12201673
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/201673 | EXPRESSION OF ACTIVE HUMAN FACTOR IX IN MAMMARY TISSUE OF TRANSGENIC ANIMALS | Aug 28, 2008 | Abandoned |
Array
(
[id] => 6614895
[patent_doc_number] => 20100310525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/675681
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 31771
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310525.pdf
[firstpage_image] =>[orig_patent_app_number] => 12675681
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/675681 | WNT pathway stimulation in reprogramming somatic cells with nuclear reprogramming factors | Aug 28, 2008 | Issued |
Array
(
[id] => 53245
[patent_doc_number] => 07772204
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-08-10
[patent_title] => 'Perlecan and growth factor for wound and cutaneous injury healing'
[patent_app_type] => utility
[patent_app_number] => 12/196992
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9823
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772204.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196992
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196992 | Perlecan and growth factor for wound and cutaneous injury healing | Aug 21, 2008 | Issued |
Array
(
[id] => 5473047
[patent_doc_number] => 20090246213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'VACCINE COMPRISING A POLYNUCLEOTIDE ENCODING AN ANTIGEN RECOGNIZED BY A CD4+ HELPER T-CELL AND A POLYNUCLEOTIDE ENCODING A TUMOR SPECIFIC OR ASSOCIATED ANTIGEN RECOGNIZED BY A CD8+ CTL'
[patent_app_type] => utility
[patent_app_number] => 12/194453
[patent_app_country] => US
[patent_app_date] => 2008-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9526
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246213.pdf
[firstpage_image] =>[orig_patent_app_number] => 12194453
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/194453 | VACCINE COMPRISING A POLYNUCLEOTIDE ENCODING AN ANTIGEN RECOGNIZED BY A CD4+ HELPER T-CELL AND A POLYNUCLEOTIDE ENCODING A TUMOR SPECIFIC OR ASSOCIATED ANTIGEN RECOGNIZED BY A CD8+ CTL | Aug 18, 2008 | Abandoned |
Array
(
[id] => 5580488
[patent_doc_number] => 20090175834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'NEURONAL PROGENITOR CELLS AND METHODS OF DERIVATION AND PURIFICATION OF NEURONAL PROGENITOR CELLS FROM EMBRYONIC STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/185695
[patent_app_country] => US
[patent_app_date] => 2008-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13481
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20090175834.pdf
[firstpage_image] =>[orig_patent_app_number] => 12185695
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/185695 | Methods of derivation of neuronal progenitor cells from embryonic stem cells | Aug 3, 2008 | Issued |
Array
(
[id] => 22904
[patent_doc_number] => 07799969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-21
[patent_title] => 'Methods for cloning rats by nuclear transfer'
[patent_app_type] => utility
[patent_app_number] => 12/184328
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5512
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/799/07799969.pdf
[firstpage_image] =>[orig_patent_app_number] => 12184328
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/184328 | Methods for cloning rats by nuclear transfer | Jul 31, 2008 | Issued |
Array
(
[id] => 5360490
[patent_doc_number] => 20090035284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'DERIVATION OF NEURAL STEM CELLS FROM EMBRYONIC STEM CELLS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/182050
[patent_app_country] => US
[patent_app_date] => 2008-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8297
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20090035284.pdf
[firstpage_image] =>[orig_patent_app_number] => 12182050
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/182050 | Derivation of neural stem cells from embryonic stem cells | Jul 28, 2008 | Issued |
Array
(
[id] => 5412133
[patent_doc_number] => 20090126032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Method to produce cloned embryos and adults from cultured cells'
[patent_app_type] => utility
[patent_app_number] => 12/221060
[patent_app_country] => US
[patent_app_date] => 2008-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17334
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0126/20090126032.pdf
[firstpage_image] =>[orig_patent_app_number] => 12221060
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/221060 | Method to produce cloned embryos and adults from cultured cells | Jul 28, 2008 | Abandoned |
Array
(
[id] => 5391146
[patent_doc_number] => 20090208459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Methods of treating anemia using recombinant adeno-associated virus virions'
[patent_app_type] => utility
[patent_app_number] => 12/218508
[patent_app_country] => US
[patent_app_date] => 2008-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16532
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208459.pdf
[firstpage_image] =>[orig_patent_app_number] => 12218508
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/218508 | Methods of treating anemia using recombinant adeno-associated virus virions | Jul 14, 2008 | Issued |
Array
(
[id] => 4948958
[patent_doc_number] => 20080305084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions'
[patent_app_type] => utility
[patent_app_number] => 12/218394
[patent_app_country] => US
[patent_app_date] => 2008-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15914
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20080305084.pdf
[firstpage_image] =>[orig_patent_app_number] => 12218394
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/218394 | Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions | Jul 14, 2008 | Issued |
Array
(
[id] => 5290423
[patent_doc_number] => 20090023153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Targeted modification of chromatin structure'
[patent_app_type] => utility
[patent_app_number] => 12/217953
[patent_app_country] => US
[patent_app_date] => 2008-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 30077
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023153.pdf
[firstpage_image] =>[orig_patent_app_number] => 12217953
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/217953 | Targeted modification of chromatin structure | Jul 9, 2008 | Issued |
Array
(
[id] => 4711056
[patent_doc_number] => 20080299582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Culture System for Rapid Expansion of Human Embryonic Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 12/170219
[patent_app_country] => US
[patent_app_date] => 2008-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15132
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299582.pdf
[firstpage_image] =>[orig_patent_app_number] => 12170219
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/170219 | Human embryonic stem cells genetically modified to contain a nucleic acid and cultured with fibroblast growth factor | Jul 8, 2008 | Issued |
Array
(
[id] => 5271016
[patent_doc_number] => 20090074792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Compositions containing full-length L1R nucleic acid and endoplasmic reticulum-targeting sequence, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/217584
[patent_app_country] => US
[patent_app_date] => 2008-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19805
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074792.pdf
[firstpage_image] =>[orig_patent_app_number] => 12217584
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/217584 | DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a tPA leader sequence | Jul 6, 2008 | Issued |
Array
(
[id] => 6636693
[patent_doc_number] => 20100173800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'DELIVERY OF NUCLEIC ACIDS INTO GENOMES OF HUMAN STEM CELLS USING IN VITRO ASSEMBLED MU TRANSPOSITION COMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 12/667853
[patent_app_country] => US
[patent_app_date] => 2008-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7330
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173800.pdf
[firstpage_image] =>[orig_patent_app_number] => 12667853
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/667853 | DELIVERY OF NUCLEIC ACIDS INTO GENOMES OF HUMAN STEM CELLS USING IN VITRO ASSEMBLED MU TRANSPOSITION COMPLEXES | Jul 3, 2008 | Abandoned |
Array
(
[id] => 8621456
[patent_doc_number] => 08354370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-15
[patent_title] => 'Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders'
[patent_app_type] => utility
[patent_app_number] => 12/140065
[patent_app_country] => US
[patent_app_date] => 2008-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 29
[patent_no_of_words] => 40148
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12140065
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/140065 | Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders | Jun 15, 2008 | Issued |